PointofLaw.com

FORUM FEATURED DISCUSSIONS PoL COLUMNS LEGAL EXPERTS ARTICLES BOOKS PODCASTS LINKS MASTHEAD ADVANCED SEARCH

FORUM

« More Milberg | A "business judgment" rule for medical malpractice? III »

June 20, 2006


Trial Lawyers, Inc. Update

Make sure to check out the new installment in the Center for Legal Policy's ongoing coverage of America's lawsuit industry. We have just released a new TLI update: The Move to Reverse Michigan's Model Reforms.

Michigan has the good fortune to be the only state in the union with an FDA defense law: once a drug has recieved FDA approval, its maker cannot be sued for damages, except in case of fraud on the part of drugmaker or government. Now, the plaintiffs' bar has launched an assault on this unique protection, putting the state in economic danger and threatening to lower the quality of its citizens health. Read and download the whole report here.

Posted by Sam Munson at 04:52 PM | TrackBack (0)



categories:
Politics
Products Liability
Vioxx/Drug Litigation









 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.